Responding to questions raise in Parliament the Ministry replied that India’s AYUSH sector, the government arm for traditional and alternative medicine, is running with nearly half of its posts ...

A possible new treatment for impaired brain blood flow and related dementias is on the horizon. Research by scientists at the University of Vermont Robert Larner, M.D. College of Medicine provides ...

Dr. Rachel Preisser of GRACE Imaging and Medical Spa discusses the impact of increasing health insurance costs and physician ...

Journalist Andy Lyman with the Lesser Known New Mexico podcast spoke with the founder of Verdes Cannabis in Albuquerque, Eric Seegle, about what a recent executive order that could reclassify ...

After 55 years since it was first considered a Schedule I drug, the Trump Administration is reclassifying marijuana as Schedule III, opening the door for medical research and marijuana as medicine.

Animal rights groups celebrate, but the Trump administration is light on specifics about phasing out federally funded medical ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

But there are always moments of great progress and hope. For example, the creation of the Global Fund for AIDS, TB, and ...

Happy Monday, and welcome to Health Brief. This is our last issue of 2025. Thank you so much for coming along on the journey of launching the Health Brief newsletter. I hope you’re able to find some ...

This comes at a time when cannabis use among boomers is, well, booming. The number of Americans aged 65+ using cannabis for ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

Trump's executive order elevates cannabis research while a new hemp ban looms, easing industry uncertainty and opening doors.